Evidence map›Paper›PMID 24305419›Full record

ArticleGene therapy2014

Quantitative morphological comparison of axon-targeting strategies for gene therapies directed to the nigro-striatal projection.

S Padmanabhan, T Kareva, N Kholodilov, R E Burke

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

S PadmanabhanDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
T KarevaDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
N KholodilovDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
R E Burke1] Department of Neurology, Columbia University Medical Center, New York, NY, USA [2] Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.
Columbia University Irving Medical Center · USColumbia University · US

Funding

TRANSLATIONAL APPROACHES TO NEUROPROTECTION OF AXONS IN PDrP50NS038370 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BURKE, ROBERT E · 1999 to 2014
$24.0M
NINDS NIH HHS NS38370
6 · The paper itself

Abstract

Cellular targeting of mRNAs and proteins to axons is essential for axon growth during development and is likely to be important for adult maintenance as well. Given the importance and potency of these axon-targeting motifs to the biology of axons, it seems possible that they can be used in the design of transgenes that are intended to enhance axon growth or maintenance, so as to improve potency and minimize off-target effects. To investigate this possibility, it is first essential to assess known motifs for their efficacy. We have therefore evaluated four axon-targeting motifs, using adeno-associated viral vector-mediated gene delivery in the nigro-striatal dopaminergic system, a projection that is predominantly affected in Parkinson's disease. We have tested two mRNA axonal zipcodes, the 3' untranslated region (UTR) of β-actin and 3' UTR of tau, and two axonal-targeting protein motifs, the palmitoylation signal sequence in GAP-43 and the last 15 amino acids in the amyloid precursor protein, to direct the expression of the fluorescent protein Tomato in axons. These sequences, fused to Tomato, were able to target its expression to dopaminergic axons. Based on quantification of Tomato-positive axons, and the density of striatal innervation, we conclude that the C-terminal of the amyloid precursor protein is the most effective axon-targeting motif.

Indexed as

Genetic Vectors3' Untranslated RegionsActinsAmino Acid MotifsAmino Acid SequenceAmyloid beta-Protein PrecursorAnimalsAxonsCorpus StriatumDependovirusDopaminergic NeuronsGAP-43 ProteinGenetic TherapyGreen Fluorescent ProteinsHEK293 CellsHumans3' Untranslated RegionsActinsAmyloid beta-Protein PrecursorGAP-43 ProteinGreen Fluorescent ProteinsRNA, Messengertau Proteins

Identifiers

PMID24305419
OpenAlexW2010290510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.